Bristol-Myers Again Rebuffs Plavix Fraud Claims
By Sam Schulz · January 8, 2008, 12:00 AM EST
Under fire from investors who insist they've sufficiently pled scienter, Bristol-Myers Squibb Co. is bolstering its bid to toss the suit that says it misled shareholders with the Plavix patent deal,...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login